Three Maryland Tech Council Leaders Named to Prescription Drug Affordability Board’s Stakeholder Council

FREDERICK, MD (March 14, 2022) — The Maryland Tech Council (MTC), the state’s largest technology and life sciences trade association, today announced that three of its leaders have been appointed to the Maryland Prescription Drug Affordability Board’s Stakeholder Council.

The appointees are Deron Johnson, Director of State Government Affairs at Amgen and MTC Board Member; Barry Lipsy, Principal at BN Lipsy & Associates and MTC Venture Mentor, and Marty Rosendale, Chief Executive Officer of MTC.

The Prescription Drug Affordability Board’s Stakeholder Council assists the Board in identifying whether the cost of a prescription drug creates affordability challenges for the State health care system and patients.

“Maryland residents and patients across the country rely on the groundbreaking health care solutions that Maryland companies create to help save lives,” said Rosendale. “I look forward to working with Deron, Barry and the Board’s members to keep prescription drugs accessible and affordable while protecting the innovation ecosystem that makes these treatments and cures possible.”

Deron Johnson is Director of State Government Affairs at Amgen, where he is responsible for shaping Amgen’s legislative and public policy on state health care issues in the Mid-Atlantic/Southeastern region. Deron maintains strong relationships with state policymakers and legislators as well as works collaboratively and cross-functionally with Amgen’s corporate accounts, legal, policy and business units on issues that impact the company at the state level.

Barry Lipsy is a marketing and business management consultant with C-Suite experience, and has grown, defended, and launched leading brands and services in three industry sectors: healthcare, government, and for profit/national consumer brands. Barry has taught marketing and strategic planning at NYU, Pepperdine, and Marymount universities. As a volunteer, Barry is a mentor in the Maryland Tech Council Venture Mentoring Service and the FedTech Start-up Studio Accelerator. A caregiver for a family member with a rare disease, Barry serves on the leadership team for CACNETS, the MD-DC-VA Carcinoid/Neuroendocrine Tumor Cancer patient support group.

As CEO of the Maryland Tech Council, Marty Rosendale leads the largest life sciences and technology association in the state. An engineer turned microbiologist and industry leader, he is five-time CEO and twice company founder. His experience spans public, private and not-for-profit businesses and has launched, branded, acquired or commercialized more than 10 products and companies.